8
Demographics Hepatitis B vaccine
Demographics
Vaccination coverage surveys
Hepatitis B vaccination coverage 2015 Districts by coverage categories 2012 Neonatal deliveries
Hepatitis B serological surveys
WHO verification
Health facility Home with SBA Home with no SBA Unknown
HONG KONG SAR (CHINA)
Survey year Location Ages enrolled Sample size HepB BD % HepB3 % DTP3 % Reference/Notes
2009 National 2-5 years 6248 not reported ≥99.5% >99.8% MoH Hong Kong 2011
Survey year Location Ages enrolled Sampling base Sample size HBsAg prevalence (95%CI) Reference/Notes
2006 Nationwide 1-4 years Laboratory based 196 1% MoH Hong Kong 2011
2009 Nationwide 12-15 years School based 1913 0.8% (0.4% - 1.2%) MoH Hong Kong 2011
Total population (2015) 7 305 700
Births (2015) 59 901
Surviving infants (2015) no data
Urban population (2015) 95%
HepB3 introduced nationwide 1988
HepB birth dose introduced 1988
Current schedule 0, 1 month, 6 months
HepB3 type Monovalent
Status of verifying prevalence targets
Verification started: February 2011
Decision: <1% in children
Decision date: July 2011
100.0%
0 20 40 60 80 100
<50% <50%-79% 80%-89% 90%-94% >94%
% District 2015
HepB3 Timely HepB BD
Abbreviations: DTP3: 3rd dose of Diphteria, Tetanus and Pertusis vaccine; HepB3: at least 3 doses of hepatitis B vaccine; HBsAg: hepatitis B surface antigen; SBA: Skilled Birth Attendant; Timely HepB BD: birth dose within 24 hours Sources: Urban Population was derived from World Bank; 2012 Neonatal deliveries was derived from the Western Pacific Country Health Information Profiles; Unless otherwise noted in the section marked References/Notes, all remaining data was derived from the WHO and UNICEF Joint Reporting Form on Immunization
*HepB3 vaccination coverage when available, otherwise graph represents DPT3 coverage.
0 20 40 60 80 100
2011 2012 2013 2014 2015
Vaccination Coverage (%)
Timely HepB BD Any HepB BD HepB3
*
